These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 30229541)

  • 1. Pediatric Multiple Sclerosis: an Update.
    Otallah S; Banwell B
    Curr Neurol Neurosci Rep; 2018 Sep; 18(11):76. PubMed ID: 30229541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of myelin oligodendrocyte glycoprotein antibodies in pediatric onset multiple sclerosis.
    Solmaz I; Doran T; Yousefi M; Konuskan B; Oncel I; Vural A; Anlar B
    Mult Scler Relat Disord; 2022 Dec; 68():104097. PubMed ID: 35998500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome.
    Hennes EM; Baumann M; Schanda K; Anlar B; Bajer-Kornek B; Blaschek A; Brantner-Inthaler S; Diepold K; Eisenkölbl A; Gotwald T; Kuchukhidze G; Gruber-Sedlmayr U; Häusler M; Höftberger R; Karenfort M; Klein A; Koch J; Kraus V; Lechner C; Leiz S; Leypoldt F; Mader S; Marquard K; Poggenburg I; Pohl D; Pritsch M; Raucherzauner M; Schimmel M; Thiels C; Tibussek D; Vieker S; Zeches C; Berger T; Reindl M; Rostásy K;
    Neurology; 2017 Aug; 89(9):900-908. PubMed ID: 28768844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
    Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
    J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and MRI phenotype of children with MOG antibodies.
    Fernandez-Carbonell C; Vargas-Lowy D; Musallam A; Healy B; McLaughlin K; Wucherpfennig KW; Chitnis T
    Mult Scler; 2016 Feb; 22(2):174-84. PubMed ID: 26041801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple Sclerosis in Children: Differential Diagnosis, Prognosis, and Disease-Modifying Treatment.
    Jakimovski D; Awan S; Eckert SP; Farooq O; Weinstock-Guttman B
    CNS Drugs; 2022 Jan; 36(1):45-59. PubMed ID: 34940954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic algorithm for relapsing acquired demyelinating syndromes in children.
    Hacohen Y; Mankad K; Chong WK; Barkhof F; Vincent A; Lim M; Wassmer E; Ciccarelli O; Hemingway C
    Neurology; 2017 Jul; 89(3):269-278. PubMed ID: 28615429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis.
    Ramanathan S; Prelog K; Barnes EH; Tantsis EM; Reddel SW; Henderson AP; Vucic S; Gorman MP; Benson LA; Alper G; Riney CJ; Barnett M; Parratt JD; Hardy TA; Leventer RJ; Merheb V; Nosadini M; Fung VS; Brilot F; Dale RC
    Mult Scler; 2016 Apr; 22(4):470-82. PubMed ID: 26163068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI and laboratory features and the performance of international criteria in the diagnosis of multiple sclerosis in children and adolescents: a prospective cohort study.
    Fadda G; Brown RA; Longoni G; Castro DA; O'Mahony J; Verhey LH; Branson HM; Waters P; Bar-Or A; Marrie RA; Yeh EA; Narayanan S; Arnold DL; Banwell B;
    Lancet Child Adolesc Health; 2018 Mar; 2(3):191-204. PubMed ID: 30169254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azathioprine therapy in a case of pediatric multiple sclerosis that was seropositive for MOG-IgG.
    Zhou Y; Huang Q; Lu T; Sun X; Fang L; Lu Z; Hu X; Kermode A; Qiu W
    J Clin Neurosci; 2017 Apr; 38():71-73. PubMed ID: 28111033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein.
    Baumann M; Sahin K; Lechner C; Hennes EM; Schanda K; Mader S; Karenfort M; Selch C; Häusler M; Eisenkölbl A; Salandin M; Gruber-Sedlmayr U; Blaschek A; Kraus V; Leiz S; Finsterwalder J; Gotwald T; Kuchukhidze G; Berger T; Reindl M; Rostásy K
    J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):265-72. PubMed ID: 25121570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases.
    Di Pauli F; Mader S; Rostasy K; Schanda K; Bajer-Kornek B; Ehling R; Deisenhammer F; Reindl M; Berger T
    Clin Immunol; 2011 Mar; 138(3):247-54. PubMed ID: 21169067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive function in pediatric-onset relapsing myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).
    Fabri TL; O'Mahony J; Fadda G; Gur RE; Gur RC; Yeh EA; Banwell BL; Till C
    Mult Scler Relat Disord; 2022 Mar; 59():103689. PubMed ID: 35183817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Autoantibodies Against Myelin Oligodendrocyte Glycoprotein in Multiple Sclerosis and Related Diseases.
    Spadaro M; Meinl E
    Methods Mol Biol; 2016; 1304():99-104. PubMed ID: 25814289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective analysis of children with myelin oligodendrocyte glycoprotein antibody-related disorders.
    Konuskan B; Yildirim M; Gocmen R; Okur TD; Polat I; Kilic H; Saltik S; Ozturk Z; Gucuyener K; Altunbasak S; Celik T; Kose G; Yilmaz A; Komur M; Kayilioglu H; Anlar B
    Mult Scler Relat Disord; 2018 Nov; 26():1-7. PubMed ID: 30212767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MOG Spectrum Disorders and Role of MOG-Antibodies in Clinical Practice.
    Hennes EM; Baumann M; Lechner C; Rostásy K
    Neuropediatrics; 2018 Feb; 49(1):3-11. PubMed ID: 28859212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paediatric acute disseminated encephalomyelitis followed by optic neuritis: disease course, treatment response and outcome.
    Wong YYM; Hacohen Y; Armangue T; Wassmer E; Verhelst H; Hemingway C; van Pelt ED; Catsman-Berrevoets CE; Hintzen RQ; Deiva K; Lim MJ; Rostásy K; Neuteboom RF
    Eur J Neurol; 2018 May; 25(5):782-786. PubMed ID: 29443442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies.
    Lee HJ; Kim B; Waters P; Woodhall M; Irani S; Ahn S; Kim SJ; Kim SM
    J Neuroinflammation; 2018 Oct; 15(1):302. PubMed ID: 30382857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Leukodystrophy-like' phenotype in children with myelin oligodendrocyte glycoprotein antibody-associated disease.
    Hacohen Y; Rossor T; Mankad K; Chong W'; Lux A; Wassmer E; Lim M; Barkhof F; Ciccarelli O; Hemingway C
    Dev Med Child Neurol; 2018 Apr; 60(4):417-423. PubMed ID: 29288492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort.
    Ketelslegers IA; Van Pelt DE; Bryde S; Neuteboom RF; Catsman-Berrevoets CE; Hamann D; Hintzen RQ
    Mult Scler; 2015 Oct; 21(12):1513-20. PubMed ID: 25662345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.